Protalix BioTherapeutics Profit Margin 1970-1969 | PLX
Current and historical gross margin, operating margin and net profit margin for Protalix BioTherapeutics (PLX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Protalix BioTherapeutics net profit margin as of December 31, 1969 is -43.21%.
|Protalix BioTherapeutics Annual Profit Margins
|Protalix BioTherapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Protalix BioTherapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of recombinant therapeutic proteins. The company's product pipeline includes ProCellEx(R). Protalix BioTherapeutics Inc. is based in CARMIEL, Israel.